Yimin Wang

Yimin Wang

Auto-generated profile, based on publicly available information

Yimin Wang

Department of Reproductive Genetics, Wenzhou People’s Hospital, Wenzhou Women and Children’s Hospital, Wenzhou, China

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2018 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
SLSiming Lu
Siming Lu
FCFabio Cuzzucoli
Fabio Cuzzucoli
JJJing Jiang
Jing Jiang
LLLiguo Liang
Liguo Liang
YWYimin Wang
Yimin Wang
SWShuQi Wang
ShuQi Wang
Cancer poses a great health threat to both developed and developing countries, and anti-cancer drugs are of important interest for improved clinical outcomes. Although tumor-on-a-chip technologies offer a feasible approach to screening drug toxicity, their capability to mimic the native tumor microenvironment (TME) is still limited. For better mimicry of the TME, we developed a biomimetic three-dimensional (3D) liver tumor-on-a-chip with the integration of essential components derived from decellularized liver matrix (DLM) with gelatin methacryloyl (GelMA) in a microfluidics-based 3D dynamic cell culture system. The biomimetic liver tumor-on-a-chip based on the integration of DLM components with GelMA, as opposed to GelMA only, had an increased capability to maintain cell viability and to enhance hepatocyte functions under flow conditions. The improved performance of the DLM–GelMA-based tumor-on-a-chip may be attributed to the provision of biochemical factors (e.g., growth factors), the preservation of scaffold proteins, and the reestablishment of biophysical cues (e.g., stiffness and shear stress) for better recapitulation of the 3D liver TME. Furthermore, this DLM–GelMA-based tumor-on-a-chip exhibited linear dose-dependent drug responses to the toxicity of acetaminophen and sorafenib. Taken together, our study demonstrates that the DLM–GelMA-based biomimetic liver tumor-on-a-chip better mimics the in vivo TME and holds great promise for a breadth of pathological and pharmacological studies.

26 July 2017 in The Analyst
Verified
Journal Article
Closed access
PDF file
SLSiming Lu
Siming Lu
TYTao Yu
Tao Yu
YWYimin Wang
Yimin Wang
LLLiguo Liang
Liguo Liang
YCYu Chen
Yu Chen
SWShuQi Wang
ShuQi Wang
Cardiovascular disease (CVD) has become the primary cause of global deaths and inflicts an enormous healthcare burden on both developed and developing countries. Frequent monitoring of CVD-associated risk factors such as the level of lipids (e.g., triglyceride (TG) and total cholesterol (TC)) and lipoproteins (e.g., low-density lipoprotein (LDL) and high-density lipoprotein (HDL)) can effectively help prevent disease progression and improve clinical outcomes. However, measurement of these risk factors is generally integrated into an automated analyzer, which is prohibitively expensive and highly instrument-dependent for routine testing in primary care settings. As such, a variety of rapid, simple and portable nanomaterial-based biosensors have been developed for measuring the level of lipids (TG and TC) and lipoproteins (LDL and HDL) towards the management of CVD at the point-of-care (POC). In this review, we first summarize traditional methods for measurement of lipids and lipoproteins, and then present the latest advances in developing nanomaterial-based biosensors that can potentially monitor the risk factors of CVD at the POC.

30 November 2004 in Science of Computer Programming
Verified
Journal Article
Closed access
YWYi-Min Wang
Yi-Min Wang
CVChad Verbowski
Chad Verbowski
JDJohn Dunagan
John Dunagan
YCYu Chen
Yu Chen
HWHelen J. Wang
Helen J. Wang
ZZZheng Zhang
Zheng Zhang

1 September 2006 in Asian Journal of Andrology
Verified
Journal Article
Open access
GYGuo-Sheng Yang
Guo-Sheng Yang
Wei WangWei Wang
Wei Wang
YWYi-Min Wang
Yi-Min Wang
ZCZhao-Dian Chen
Zhao-Dian Chen
SWShuo Wang
Shuo Wang
JFJia-Jie Fang
Jia-Jie Fang
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.

1 December 2018 in Analytica Chimica Acta
Verified
Journal Article
Closed access
LLLiguo Liang
Liguo Liang
YWYimin Wang
Yimin Wang
SLSiming Lu
Siming Lu
MKMengqi Kong
Mengqi Kong
YLYONG LIN
YONG LIN
SWShuQi Wang
ShuQi Wang

1 January 2022 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
YWYimin Wang
Yimin Wang
SLSiming Lu
Siming Lu
JZJiayong Zheng
Jiayong Zheng
LLLiguo Liang
Liguo Liang
In recent years, nanotechnology has attracted much attention in the field of biomedicine and sensing technology. As one of the simplest and most effective methods to prepare nanofiber materials, electrospinning technology has a lot of application research in biomedical fields such as sensor detection, drug delivery, and tissue engineering because of its high porosity, large surface area to volume ratio, and uniform size. In this review, we summarized the latest application progress of electrospinning materials in biomedicine, sensing, and textile industry and discussed the challenges and future development direction of electrospinning technology.